Hemosol B0 otopina za hemodijalizu/hemofiltraciju
| Name | Hemosol B0 otopina za hemodijalizu/hemofiltraciju |
|---|---|
| Marketing Authorisation Number | HR-H-037692627 |
| Active Substance | kalcijev klorid dihidrat magnezijev klorid heksahidrat natrijev klorid laktatna kiselina natrijev hidrogenkarbonat |
| Composition | 1000 ml otopine za hemofiltraciju i hemodijalizu sadrži: 1,75 mmol/l kalcija, Ca2+; 0,5 mmol/l magnezija, Mg2+;140 mmol/l natrija, Na+; 109,5 mmol/l klorida, Cl-; 3 mmol/l laktata, C3H5O3- i 32 mmol/l hidrogenkarbonata, HCO3- |
| Pharmaceutical Form | Otopina za hemodijalizu / hemofiltraciju |
| Manufacturer | Bieffe Medital S.p.A., Sondalo (SO), Italija Vantive Manufacturing Limited, Castlebar, County Mayo, Irska |
| Marketing Authorisation Holder | Baxter Holding B.V., Kobaltweg 49, Utrecht, Nizozemska |
| Marketing Authorisation Date | 30.09.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/12 |
| Registration Number | 381-12-01/154-21-36 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | B05ZB |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
